Physician profile
Johnny Lim
NPI 1598254468
$1,341.15
in general payments reported to CMS, 2019-2025
15 companies · $479 in 2025
The $479 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $131 · 2022: $43.96 · 2023: $186 · 2024: $501 · 2025: $479.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,167.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,166.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $497.53 | 2024-2025 | Gmrs, T2 Alpha, Triathlon |
| Amgen INC. | $265.00 | 2024 | Evenity, Prolia |
| Arthrex, INC. | $153.83 | 2023 | |
| Horizon Therapeutics Plc | $89.75 | 2021-2022 | |
| Radius Health, INC. | $57.18 | 2021 | |
| Solventum Corporation | $54.69 | 2024-2025 | Prevena, V.A.C.Ulta |
| Acera Surgical, INC. | $33.21 | 2025 | Restrata Wound Matrix |
| Saxum Surgical, INC. | $32.51 | 2023 | |
| Innovation Technologies INC | $31.23 | 2025 | Irrisept |
| Integra Lifesciences Corporation | $30.60 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Phathom Pharmaceuticals, INC. | $28.72 | 2024 | Voquezna |
| Pfizer INC. | $23.42 | 2024 | |
| Abbvie INC. | $15.86 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $15.85 | 2024 | Libtayo |
| Boston Scientific Corporation | $11.77 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Johnny Lim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.